STMN1 and neoplasm: In multivariate survival analyses (METABRIC cohorts), adjusting for tumour size, histological grade and lymph node status, high stathmin mRNA expression independently associated with shorter disease specific survival (discovery cohort: HR = 1.6, 95% CI 1.2–2.1; p = 0.001; validation cohort: HR = 1.7, 95% CI 1.3–2.3; p < 0.001).